Skip to content
Last sale
Nov 12, 2026 · -2.20%
Market cap
$143.98M
11.18M shares
Filings
1,021
$72.05M
Q3 2026−36.0% FY25 yoy
-$17.51M
Q3 2026N/M FY25 yoy
-$19.36M
Q3 2026N/M FY25 yoy
$2.76M
Q3 2026derived−92.7% FY25 yoy
-$1.57
Q3 2026N/M FY25 yoy
$58.37M
Q3 2026−1.8% FY25 yoy
$143.98M
—
0.5×
0.8×
-2.69%
0.12%

Twelve months to Sep 30, 2026 · derived

Price

$12.88+10.75%+$1.25past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$385.79MFY 2025
$1.60B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$385,788,000reported
FY 20242024-12-31$602,463,000reported
FY 20232023-12-31$1,072,054,000reported
FY 20222022-12-31$1,598,577,000reported
FY 20212021-12-31$1,526,087,000reported
FY 20202020-12-31$934,842,000reported
FY 20192019-12-31$713,672,000reported
FY 20182018-12-31$501,003,000reported
FY 20172017-12-31$301,563,000reported
FY 20162016-12-31$274,534,000reported
FY 20152015-12-31$272,773,000reported
FY 20142014-12-31$285,285,000reported

Capital returns

Dividends and buybacks · FY2014 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025$195.00K$0.00$195.00K$0.0010.99M sh+0.5%15.6%
FY2024$715.00K$0.00$715.00K$0.0010.94M sh+0.4%4.2%
FY2023$73.02M$3.60M$76.62M$4.9510.90M sh+0.5%54.3%
FY2022$71.62M$126.45M$198.07M$6.5610.84M sh−6.0%111.3%
FY2021$63.86M$56.00M$119.86M$5.6811.54M sh−2.0%198.6%

Miscellaneous food preparations & kindred products

Medifast Inc is the 3rd largest of the 5 covered companies the SEC files under this code, by revenue. SIC 2090

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Medifast Inc · CIK 910329 · Engraved from SEC EDGAR